Pigmentation is one of the most frequently treated and most frequently misunderstood skin concerns.
Brown spots, uneven tone, patches of discolouration and lingering marks are often grouped beneath a single word. A laser or light-based treatment is then selected with the expectation that visible pigment should simply disappear.
Skin is rarely that straightforward.
What appears brown at the surface may be caused by cumulative sun exposure, hormonal activity, inflammation, injury, medication or a pigmentary disorder. It may sit within the epidermis, extend deeper into the dermis or involve both layers. In some cases, what appears to be pigmentation may not be suitable for cosmetic treatment at all.
This is why treating pigment should never begin with the device.
It should begin with understanding what the pigment is, where it is located and what continues to drive it.
Pigmentation is a description of colour. It is not a diagnosis. Effective pigmentation treatment depends on identifying the type, depth and cause of the discolouration before selecting skincare, laser, IPL or another clinical approach.
At Aesthete, pigmentation is assessed as a biological process not simply a mark to be removed.
What is skin pigmentation?
Skin colour is influenced by melanin, a pigment produced by specialised cells called melanocytes.
Melanin plays an important protective role by absorbing and dispersing ultraviolet radiation. The amount, type and distribution of melanin differ between individuals and contribute to natural variations in skin colour.
When melanocyte activity or the distribution of melanin changes, areas of the skin may become darker, lighter or uneven.
Hyperpigmentation describes skin that has become darker than the surrounding area. Hypopigmentation describes a reduction in pigment. Depigmentation refers to a more complete absence of pigment.
These are broad descriptions rather than individual diagnoses. As DermNet’s clinical overview of pigmentation disorders explains, localised hyperpigmentation can arise from many different causes including sun exposure, inflammation, medication, hormonal influences, benign lesions and, importantly, some skin cancers.
The first task is therefore not to remove the colour.
It is to identify it correctly.
Why does pigmentation develop?
Pigment production can be influenced by several overlapping factors.
Ultraviolet exposure
Ultraviolet radiation stimulates melanocytes to produce more melanin. This is part of the skin’s response to UV exposure, but the protection it provides is limited.
Over time, cumulative exposure can contribute to freckles, solar lentigines, uneven pigmentation and broader signs of photodamage. These changes are particularly relevant on frequently exposed areas such as the face, neck, décolletage, shoulders, arms and hands.
On the Sunshine Coast, sun exposure is not a minor lifestyle detail. It is often central to both the development and recurrence of pigmentation.
Hormonal influences
Hormonal change may increase melanocyte activity and contribute to conditions such as melasma.
Pigmentation may emerge or become more visible during pregnancy, when using certain hormonal medications, or through other periods of hormonal fluctuation. Hormones are rarely the only influence; ultraviolet radiation, visible light, heat, genetics and inflammation may also contribute.
This helps explain why hormonally influenced pigmentation can remain difficult to control even after the original hormonal trigger has changed.
Inflammation and injury
Skin can produce excess pigment following inflammation, irritation or physical injury. This is known as post-inflammatory hyperpigmentation.
It may develop after acne, dermatitis, burns, picking, friction, aggressive skincare or a clinical procedure. It is more common and may be more persistent in darker skin types, although it can occur in any skin.
In these cases, treating pigment without controlling the inflammation that produced it can be counterproductive.
Genetics
Genetics influence natural skin colour, melanocyte behaviour and an individual’s tendency to develop freckles, melasma or post-inflammatory pigmentation.
Two people with similar sun exposure may therefore develop very different patterns of discolouration.
Medication and medical conditions
Certain medications may contribute to photosensitivity or changes in pigmentation. Some medical conditions can also produce localised or generalised changes in skin colour.
A comprehensive medical and treatment history is therefore part of responsible pigmentation assessment. Where the presentation is unusual, widespread or outside the scope of cosmetic skin practice, medical referral may be required.
Not all brown spots are the same
The term pigmentation is routinely used to describe several clinically different presentations.
Understanding those differences changes the treatment plan.
Freckles
Freckles, or ephelides, are small areas of increased pigmentation that commonly become more visible with sun exposure.
They often appear during childhood or early adulthood and may darken during summer before fading during periods of reduced ultraviolet exposure. Genetics strongly influence who develops them.
Selected freckles may respond to light-based or pigment-targeting treatments. However, a person’s tendency to produce freckles remains. Without ongoing sun protection, new pigmentation may appear and treated areas may darken again.
Treatment does not remove the skin’s underlying response to ultraviolet exposure.
Solar lentigines and sun-related pigmentation
Solar lentigines are well-defined pigmented marks associated with cumulative ultraviolet exposure. They are sometimes called sun spots, liver spots or age spots, although they are unrelated to liver function.
Unlike freckles, solar lentigines do not usually fade significantly when sun exposure decreases.
They frequently appear on the face, décolletage and hands and may respond to appropriately selected IPL or pigment-targeting laser treatment.
However, not every isolated brown lesion is a solar lentigo. Clinical examination must come before cosmetic treatment, particularly when a lesion is new, changing, irregular or different from the surrounding marks.
Post-inflammatory hyperpigmentation
Post-inflammatory hyperpigmentation develops after the skin has been inflamed or injured.
The pigment is not the original condition. It is the skin’s response to it.
Common triggers include:
- Acne and inflammatory breakouts
- Dermatitis or eczema
- Burns
- Skin picking
- Friction
- Inappropriate exfoliation
- Aggressive skincare
- Laser, light or energy-based treatment
- Other forms of physical or chemical injury
Treatment must account for both the residual pigment and the skin’s tendency to become inflamed.
If active acne, dermatitis or barrier disruption remains uncontrolled, immediately pursuing the pigment may create further inflammation and further pigmentation.
The first stage may involve stabilising the skin, reducing irritation and preventing new lesions before stronger corrective treatment is introduced.
Melasma
Melasma commonly presents as symmetrical patches of brown or grey-brown discolouration, often across the cheeks, forehead, upper lip or jawline.
It is a complex, chronic and frequently recurrent pigmentary condition. Hormones, genetics, ultraviolet radiation, visible light, heat and inflammation may all influence its behaviour.
Melasma should not be approached as though it were ordinary sun damage.
A treatment that improves solar lentigines may be inappropriate for melasma. Excessive heat, inflammation or poorly selected light-based treatment can provoke further pigment production and cause the condition to darken.
Management may involve strict photoprotection, pigment-regulating skincare, barrier support, carefully selected clinical treatments and ongoing review. Device-based treatment is not automatically the first or best option.
There is also no honest basis for promising permanent clearance.
Melasma can improve, stabilise and become less visible, but its underlying tendency may remain. Long-term management is often more realistic than the language of removal.
Dermal pigmentation
Some pigment is located deeper within the skin.
Dermal pigmentation can appear grey, blue-grey or diffuse because of how light interacts with pigment beneath the epidermis. It may occur in melasma, post-inflammatory pigmentation and other pigmentary conditions.
Deeper pigment generally behaves differently from superficial epidermal pigment and may respond more slowly or require a different treatment pathway.
This is one reason visual inspection alone has limitations. Colour, distribution, history and advanced skin imaging may all contribute to understanding where the pigment is likely to sit.
When discolouration is not caused by melanin
Not all visible discolouration is pigment in the conventional sense.
Red or purple marks may be vascular rather than melanin-based. Brown staining may sometimes involve blood products such as haemosiderin. Certain infections, inflammatory conditions and medical disorders can also alter skin colour.
Treating vascular redness with a pigment-focused approach—or treating a pigmented lesion as though it were redness—can produce little benefit and introduce unnecessary risk.
The colour visible at the surface does not tell the entire story.
Why pigmentation assessment matters
A pigmentation consultation should answer more than “Can this be lasered?”
It should examine:
- The appearance and distribution of the pigment
- How long it has been present
- Whether it changes with sun, heat or hormonal activity
- Whether inflammation or injury preceded it
- The person’s skin type and pigment response
- Current skincare and active ingredients
- Medication and medical history
- Previous treatments and their outcomes
- Recent ultraviolet exposure
- History of melasma or post-inflammatory pigmentation
- Whether the lesion is appropriate for cosmetic treatment
- The likelihood of recurrence
- Whether medical assessment is required
At Aesthete, a [Clinical Skin Consultation] may also incorporate advanced imaging to examine pigmentation patterns beneath ordinary surface visibility.
Imaging can reveal broader distributions of sun-related change, areas of uneven pigment and features that may not be immediately obvious in standard light. It also provides a baseline through which the skin can be reviewed over time.
Imaging does not replace clinical knowledge, and it cannot determine that every visible mark is safe to treat. Its value lies in improving observation and supporting a more complete treatment plan.
When a pigmented lesion should not be treated cosmetically
A cosmetic clinic should never assume that every brown lesion is benign.
A lesion should receive medical assessment before cosmetic treatment if it is:
- New or changing
- Asymmetrical
- Irregular in shape or border
- Uneven in colour
- Increasing in size
- Bleeding, crusting or failing to heal
- Itching, painful or otherwise symptomatic
- Visibly different from the person’s other lesions
- Clinically uncertain for any reason
Australia has one of the highest rates of skin cancer in the world. Any uncertainty must take priority over cosmetic treatment.
The Cancer Council Australia guide to checking for signs of skin cancer recommends seeking medical advice for new or changing spots. Cosmetic laser or IPL should not be used to remove or obscure a lesion that has not been appropriately assessed.
A professional skin consultation is not a substitute for a full skin cancer examination by a suitably qualified medical practitioner.
How is pigmentation depth assessed?
Pigmentation is often described as epidermal, dermal or mixed.
Epidermal pigment
Epidermal pigment sits closer to the skin’s surface and often appears light to dark brown. Selected forms may respond to skincare, exfoliation, IPL or pigment-targeting laser treatment.
Response still depends on the diagnosis, skin type, treatment parameters and underlying trigger.
Dermal pigment
Dermal pigment lies deeper within the skin and may appear grey, blue-grey or less clearly defined.
Because the pigment is deeper, treatment may be more complex and outcomes less predictable. Attempts to treat it too aggressively may stimulate inflammation and produce further discolouration.
Mixed pigmentation
Many presentations contain both epidermal and dermal components.
Melasma, for example, may involve pigment at more than one depth alongside vascular and inflammatory influences. A single treatment aimed at one component may therefore be insufficient—or may improve one part while destabilising another.
Depth matters, but it is not the only factor. The biological behaviour of the pigmentation matters just as much.
Which treatments may be used for pigmentation?
There is no universal pigmentation treatment.
A clinical plan may involve skincare, sun protection, clinical facials, peels, IPL, PICO laser or a staged combination. The correct approach depends on what is being treated and how the skin is likely to respond.
Clinical skincare
Home care is not an optional extra in pigmentation management.
Professionally selected skincare may be used to:
- Support skin-barrier function
- Regulate pathways involved in pigment production
- Reduce inflammation
- Improve tolerance before clinical treatment
- Support recovery after treatment
- Reduce the risk of further pigment formation
- Maintain improvement between appointments
More aggressive skincare is not automatically more effective. Combining multiple acids, exfoliants and high-strength active ingredients can disrupt the barrier and provoke inflammation.
For skin prone to post-inflammatory pigmentation or melasma, that inflammation may worsen the very concern being treated.
A useful pigmentation prescription should be purposeful enough to influence the skin and controlled enough to remain tolerable.
Sun and visible-light protection
Pigmentation treatment without daily photoprotection is a contradiction.
Broad-spectrum SPF 50+ sunscreen, appropriate application and regular reapplication are central to reducing further ultraviolet stimulation. Hats, shade and avoiding unnecessary direct exposure also matter.
For some pigmentary conditions, visible light and heat may also be relevant. This may influence the type of sunscreen or additional protective measures recommended.
Sun protection does not remove established dermal pigment, but it can reduce repeated stimulation and help protect the improvement achieved through treatment.
No laser can compensate for unprotected daily exposure indefinitely.
Clinical facials and peels
Clinical facials or peels may support selected forms of superficial pigmentation through controlled exfoliation, hydration, barrier support or the delivery of targeted formulations.
Their intensity must be matched to the skin.
A deeper peel is not automatically a better peel. Excessive inflammation can create post-inflammatory pigmentation, particularly in darker or highly reactive skin types.
These treatments may form part of a broader plan, but they should not be presented as a universal answer for melasma, dermal pigment or uncertain lesions.
LimeLight IPL
Intense pulsed light uses a broad spectrum of light rather than the single wavelength associated with a laser.
Aesthete’s [LimeLight IPL treatment] may be appropriate for selected superficial brown pigmentation, freckles, solar lentigines, redness and visible vascular change associated with photodamage.
The light is absorbed by selected targets within the skin. Treated pigment may initially darken before gradually moving towards the surface and shedding.
IPL is not appropriate for every skin type or every form of pigmentation. Recent tanning, melasma, certain medications, active inflammation and a tendency towards post-inflammatory pigmentation may alter suitability or risk.
Potential complications can include burns, blistering, hyperpigmentation, hypopigmentation and scarring. Appropriate skin typing, patient selection, device settings and aftercare are essential.
IPL should never be performed simply because a brown mark is visible.
PICO laser
Picosecond laser technology delivers energy in extremely short pulses and may be used for selected pigmentary concerns and tattoo ink.
At Aesthete, [PICO laser treatment for pigmentation] may be considered when the wavelength and treatment approach are appropriate for the pigment being assessed.
PICO technology does not make diagnosis less important. Different pigment colours, depths and causes respond differently, and the risk of post-inflammatory change remains.
Multiple sessions may be required. Some pigmentation may only partially respond, and recurrence is possible when the underlying trigger remains active.
The sophistication of the technology does not remove the need for clinical restraint.
Can pigmentation be permanently removed?
Sometimes an individual benign lesion may clear following treatment and not return in exactly the same place.
That is not the same as permanently removing a person’s tendency to develop pigmentation.
New sun-related pigment can form. Freckles may reappear with ultraviolet exposure. Post-inflammatory pigmentation may return after new inflammation. Melasma may recur in response to hormones, light, heat or other triggers.
Long-term results depend on:
- The type and depth of pigmentation
- Whether the underlying cause remains active
- Daily photoprotection
- Skin-barrier stability
- Hormonal influences
- Ongoing inflammation
- Home-care consistency
- Treatment selection
- The individual biological response
The word removal can therefore create an unrealistic expectation.
For many people, the more accurate objective is improvement, control and reduced recurrence.
Why stronger treatment can create more pigmentation
Pigment-producing cells respond to injury and inflammation.
This means an aggressive attempt to clear pigmentation can sometimes stimulate further melanocyte activity. The result may be post-inflammatory hyperpigmentation, worsening melasma or uneven loss of pigment.
Risk may increase when:
- The diagnosis is incorrect
- Treatment energy is excessive
- The skin has been recently exposed to the sun
- The skin barrier is unstable
- The person has a higher risk of post-inflammatory pigmentation
- Preparation and aftercare are inadequate
- Treatments are performed too closely together
- Active inflammation is present
- The wrong technology is used for the pigment or skin type
This is why treatment intensity should never become the measure of treatment quality.
The goal is not to create the strongest possible reaction. It is to create an appropriate biological response while controlling avoidable risk.
Why treatment sequencing matters
Pigmentation plans are often staged because the skin may need preparation before a device is introduced.
A treatment pathway may begin with:
- Identifying the likely form of pigmentation
- Excluding lesions requiring medical assessment
- Stabilising inflammation or barrier dysfunction
- Introducing appropriate skincare and photoprotection
- Reviewing how the pigment responds
- Selecting IPL, PICO laser or another treatment if appropriate
- Allowing adequate recovery between procedures
- Reassessing before progressing further
- Establishing a maintenance strategy
Beginning with skincare or barrier support does not mean the plan is less advanced. It means the skin is being prepared to tolerate treatment more safely.
Likewise, delaying a procedure during periods of high sun exposure may protect the outcome rather than postpone it unnecessarily.
What should patients ask before pigmentation treatment?
Before proceeding, patients should understand:
- What type of pigmentation is suspected?
- Has the lesion been assessed as appropriate for cosmetic treatment?
- Is the pigment superficial, deep or mixed?
- What may be driving it?
- Why has this treatment been selected?
- Is my skin type suitable for the technology?
- Could the treatment worsen melasma or post-inflammatory pigmentation?
- What preparation is required?
- What are the material risks and limitations?
- What recovery should I expect?
- How many sessions may be required?
- How will recurrence be managed?
- What happens if the pigment does not respond as expected?
If the only explanation offered is that the device “targets pigment,” the assessment is incomplete.
A more intelligent approach to pigmentation
People often arrive asking for IPL, PICO laser or a particular peel because they have already decided what the brown mark must be.
That decision should not be theirs to make alone.
At Aesthete, pigmentation treatment begins through [advanced skin analysis and clinical consultation]. We examine the skin’s appearance, history, likely pigment type, depth, contributing influences and suitability before recommending a treatment pathway.
That pathway may include clinical skincare, pigment-regulating formulations, barrier support, clinical facials, LimeLight IPL, PICO laser or medical referral. It may also involve waiting until the skin is more stable or ultraviolet exposure can be better controlled.
Pigmentation can be complex, persistent and deeply influenced by the way the skin responds to inflammation.
The answer is not to treat every mark more aggressively.
It is to understand each one more accurately.
The right pigmentation treatment is not the one capable of targeting brown colour. It is the one selected after establishing why that colour is there.
Frequently Asked Questions
What causes skin pigmentation?
Pigmentation may be influenced by ultraviolet exposure, hormones, inflammation, injury, genetics, medication and some medical conditions. Different causes can produce similar-looking discolouration, which is why assessment should occur before treatment.
What is the difference between pigmentation and melasma?
Pigmentation is a broad term describing changes in skin colour. Melasma is a specific, chronic pigmentary condition commonly influenced by hormones, ultraviolet radiation, visible light, heat and genetics. It requires a different approach from ordinary freckles or sun spots.
Is IPL or PICO laser better for pigmentation?
Neither is universally better. IPL may be appropriate for selected superficial sun-related pigmentation and redness, while PICO laser may be considered for particular pigment types and depths. Suitability depends on the diagnosis, skin type, medical history and risk of post-inflammatory change.
Can laser make pigmentation worse?
Yes. Laser, IPL and other clinical treatments can provoke inflammation and may cause hyperpigmentation or hypopigmentation. Risk varies according to the technology, treatment settings, skin type, pigment condition, recent sun exposure and individual response.
Can melasma be permanently removed?
Melasma is generally regarded as a chronic and recurrent condition. It may improve with appropriate management, but hormonal activity, ultraviolet radiation, visible light, heat and inflammation can cause it to return. Long-term control is a more realistic objective than permanent removal.
Why does pigmentation become darker after IPL?
Appropriately targeted superficial pigment may temporarily darken after IPL as it absorbs light energy. It may then gradually move towards the surface and shed. Unexpected, persistent or extensive darkening should be reviewed by the treating clinic.
Does sunscreen improve pigmentation?
Broad-spectrum sunscreen helps reduce further ultraviolet stimulation and is central to pigmentation management. It will not necessarily remove established pigment, particularly pigment located deeper within the skin, but it can help reduce darkening and recurrence.
When should a brown spot be checked by a doctor?
A new, changing, irregular, bleeding, symptomatic or unusual pigmented lesion should be medically assessed before cosmetic treatment. A clinical skin consultation does not replace a comprehensive skin cancer examination.
Where can I have pigmentation treatment on the Sunshine Coast?
Aesthete provides pigmentation assessment and clinical treatment in Maroochydore on the Sunshine Coast. Depending on suitability, treatment planning may include advanced skin imaging, clinical skincare, LimeLight IPL, PICO laser or medical referral.
